A network model of a cooperative genetic landscape in brain tumors.
about
Large-scale data integration framework provides a comprehensive view on glioblastoma multiformeYME1L controls the accumulation of respiratory chain subunits and is required for apoptotic resistance, cristae morphogenesis, and cell proliferationRecent advances in the molecular understanding of glioblastomaEpigenetic dysregulation: a novel pathway of oncogenesis in pediatric brain tumorsConnexin 30 expression inhibits growth of human malignant gliomas but protects them against radiation therapy.The future role of personalized medicine in the treatment of glioblastoma multiformeTargeting the adaptability of heterogeneous aneuploidsDistinct patterns of somatic alterations in a lymphoblastoid and a tumor genome derived from the same individualThe accuracy of survival time prediction for patients with glioma is improved by measuring mitotic spindle checkpoint gene expressionDifferential expression of type 2 3α/type 5 17β-hydroxysteroid dehydrogenase (AKR1C3) in tumors of the central nervous system.JOINT AND INDIVIDUAL VARIATION EXPLAINED (JIVE) FOR INTEGRATED ANALYSIS OF MULTIPLE DATA TYPES.Glioblastoma multiforme: exploratory radiogenomic analysis by using quantitative image features.Identifying core gene modules in glioblastoma based on multilayer factor-mediated dysfunctional regulatory networks through integrating multi-dimensional genomic data.Cell cycle and aging, morphogenesis, and response to stimuli genes are individualized biomarkers of glioblastoma progression and survival.Identification of networks of co-occurring, tumor-related DNA copy number changes using a genome-wide scoring approach.Metabotropic glutamate receptors as a new therapeutic target for malignant gliomasWhole-genomic survey of oligodendroglial tumors: correlation between allelic imbalances and gene expression profiles.RIZ1 negatively regulates ubiquitin-conjugating enzyme E2C/UbcH10 via targeting c-Myc in meningioma.POLD2 and KSP37 (FGFBP2) correlate strongly with histology, stage and outcome in ovarian carcinomas.Amplicon-dependent CCNE1 expression is critical for clonogenic survival after cisplatin treatment and is correlated with 20q11 gain in ovarian cancer.Lineage-specific splicing of a brain-enriched alternative exon promotes glioblastoma progression.AKT pathway genes define 5 prognostic subgroups in glioblastoma.CDCOCA: a statistical method to define complexity dependence of co-occuring chromosomal aberrations.Rationally designed pharmacogenomic treatment using concurrent capecitabine and radiotherapy for glioblastoma; gene expression profiles associated with outcome.Polymorphisms of LIG4, BTBD2, HMGA2, and RTEL1 genes involved in the double-strand break repair pathway predict glioblastoma survivalA compendium of genome-wide associations for cancer: critical synopsis and reappraisal.Why is there a lack of consensus on molecular subgroups of glioblastoma? Understanding the nature of biological and statistical variability in glioblastoma expression data.Multi-tiered genomic analysis of head and neck cancer ties TP53 mutation to 3p loss.The discovery of putative urine markers for the specific detection of prostate tumor by integrative mining of public genomic profiles.Copy number analysis identifies novel interactions between genomic loci in ovarian cancermiRNA expression profiling in migrating glioblastoma cells: regulation of cell migration and invasion by miR-23b via targeting of Pyk2.Identification of a NFKBIA polymorphism associated with lower NFKBIA protein levels and poor survival outcomes in patients with glioblastoma multiforme.MicroRNAome and expression profile of developing tooth germ in miniature pigsGenome-wide comparison of paired fresh frozen and formalin-fixed paraffin-embedded gliomas by custom BAC and oligonucleotide array comparative genomic hybridization: facilitating analysis of archival gliomas.Reverse engineering of modified genes by Bayesian network analysis defines molecular determinants critical to the development of glioblastoma.Monosomy of chromosome 10 associated with dysregulation of epidermal growth factor signaling in glioblastomas.Network signatures of survival in glioblastoma multiforme.The path to clinical proteomics research: integration of proteomics, genomics, clinical laboratory and regulatory science.Correlation of somatic mutation and expression identifies genes important in human glioblastoma progression and survival.Advancing a clinically relevant perspective of the clonal nature of cancer
P2860
Q21183973-55EAB7B8-E777-4601-BC0F-D061D21DC137Q24302280-41FC9495-A3F0-43C1-B011-530CCF787F84Q24632928-49B7AE0D-F45E-4446-BD3D-7AAC1A935B95Q26864920-57B757E1-59AB-4994-B174-4B8AA56F0BD9Q27322751-3162D86F-2910-4692-8BF7-81A2CCB337EBQ28391635-F7CF51F5-BF1E-4DA5-8147-B8B326F62639Q28649939-BA365615-93E6-4245-9FF1-3FC42F039CDBQ28741663-A34FFFE7-B071-4CE5-8F89-E2A77DFFA3BFQ28743982-135CF60B-3BF7-4661-8EA6-C66BEC6C3E7BQ30478225-40B0AFBA-602B-42EC-8192-75F67A5076FEQ30642591-29745F5E-6224-4389-AE09-F892A3F8063CQ30820677-2366ABD5-D21E-4B52-8C9E-4AA9AB1B4A76Q30887798-D5C2F452-B01A-40E5-B716-4D64B96AC30CQ31016728-5DBEB11D-3392-4046-B2AA-F9C6250BDF8AQ33522193-99F5F9D5-1674-4ABF-B7F0-0BFD69A6AF18Q33591900-695AEA5A-82FE-4A39-B81A-45776F86C8ABQ33685875-C74D5B49-E095-4D92-A702-349342841535Q33733305-AC44F30F-2A68-4C86-A3B1-0F58CDF7A2D5Q33747847-72B1D169-B9AF-47DA-B932-F684955C3FC6Q33754744-3E62C06A-6915-4E60-9E39-5AE812F99B35Q33808359-B6EDC60F-52B1-47F0-8B45-E7898456370FQ33830769-6E94E682-F0B8-4705-95C4-DDB7AF8F1288Q33836308-8EA32284-A6B8-425D-B4BA-F2DFC7D8633CQ33853588-2F563E99-4A81-4342-900E-256FC7D5DDBAQ33897620-E15DFA1B-5736-4D94-845E-3500E2BAE76BQ33915049-DB97C59B-F65F-4E93-93C7-4EF85F105F68Q33987614-43D4950A-B7A4-4860-A090-03847685CE57Q34098286-46456CF9-BE01-4F90-B331-86DF44D1CD88Q34110104-E8B94596-D101-49B0-9FAA-C76E95F77C16Q34117394-D4182B2D-D9DF-4A0F-9E39-4F71A1E28199Q34321677-1C6B8028-62C0-4505-947C-A0ABD6FC8B44Q34350420-389E6C62-5951-4381-BB34-353217BBE8EAQ34526063-07D0A9BE-1543-4BA6-9EDA-312045532CC5Q34687243-D5F792B9-8E40-4BC4-97F0-B6E7B26E2EC3Q34758639-63E9590B-424B-4796-8446-737391773233Q34952032-DCC23DD8-6A7A-43B3-8CAF-0B25F748ED86Q34998178-CE3E0013-A191-4192-9DD4-271C3D1E7EADQ35048047-A8CC49A9-99EE-4FFF-8FE5-0AC2543468ADQ35085742-E7C16681-5594-43BC-BCD6-05CDEC2AF375Q35123202-852CD36D-9C3E-4158-AA2C-952B87F6C7DD
P2860
A network model of a cooperative genetic landscape in brain tumors.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
A network model of a cooperative genetic landscape in brain tumors.
@ast
A network model of a cooperative genetic landscape in brain tumors.
@en
A network model of a cooperative genetic landscape in brain tumors.
@nl
type
label
A network model of a cooperative genetic landscape in brain tumors.
@ast
A network model of a cooperative genetic landscape in brain tumors.
@en
A network model of a cooperative genetic landscape in brain tumors.
@nl
prefLabel
A network model of a cooperative genetic landscape in brain tumors.
@ast
A network model of a cooperative genetic landscape in brain tumors.
@en
A network model of a cooperative genetic landscape in brain tumors.
@nl
P2093
P2860
P356
P1476
A network model of a cooperative genetic landscape in brain tumors.
@en
P2093
Ajay K Yadav
Branimir I Sikic
Claudia Bredel
Denise M Scholtens
Griffith R Harsh
Hannes Vogel
Jaclyn J Renfrow
James P Chandler
Markus Bredel
P2860
P304
P356
10.1001/JAMA.2009.997
P407
P577
2009-07-01T00:00:00Z